Viewing Study NCT01388959


Ignite Creation Date: 2025-12-24 @ 3:07 PM
Ignite Modification Date: 2026-01-14 @ 4:22 AM
Study NCT ID: NCT01388959
Status: COMPLETED
Last Update Posted: 2016-11-02
First Post: 2011-07-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of MabThera/Rituxan (Rituximab) in Patients With Follicular Non-Hodgkin's Lymphoma
Sponsor: Hoffmann-La Roche
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: M39012
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators